JR
Congress trade
Sen. John Reed (D-RI) bought $1K-$15K of Celgene Corporation (CELG) stock
John Reed, U.S. Senator (D-RI), disclosed a purchase of Celgene Corporation (CELG) stock worth $1K-$15K in a STOCK Act filing on Mar 9, 2017.
The trade happened on Feb 21, 2017, 16 days before it was made public.
- Traded
- Feb 21, 2017
- Disclosed
- Mar 9, 2017
- Filing delay
- 16 days
- Source
- STOCK Act disclosure
Other trades in this disclosure (1)
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.